HomeBCTX • NASDAQ
add
Briacell Therapeutics Corp
Previous close
$2.93
Day range
$2.89 - $3.13
Year range
$2.78 - $29.40
Market cap
27.28M CAD
Avg Volume
678.73K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.33M | -31.44% |
Net income | -6.13M | -457.10% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -6.30M | 31.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.46M | 1,231.66% |
Total assets | 17.00M | 174.08% |
Total liabilities | 5.06M | -59.31% |
Total equity | 11.94M | — |
Shares outstanding | 6.78M | — |
Price to book | 1.55 | — |
Return on assets | -120.01% | — |
Return on capital | -208.60% | — |
Cash Flow
Net change in cash
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -6.13M | -457.10% |
Cash from operations | -7.16M | -40.89% |
Cash from investing | -105.00K | 53.33% |
Cash from financing | 14.71M | — |
Net change in cash | 7.45M | 240.27% |
Free cash flow | -5.00M | -205.93% |
About
Founded
2006
Headquarters
Website
Employees
17
